​
Login / Signup
Wei Heng
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 4
Top Topics
Case Report
Advanced Non Small Cell Lung Cancer
Tyrosine Kinase
Primary Care
Top Venues
JMIR cancer
Clinical Medicine Insights. Oncology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Di Zheng
,
Yanhong Shang
,
Jian Ni
,
Ling Peng
,
Xiaoming Tan
,
ZhaoXia Dai
,
Yizhuo Zhao
,
Aiqin Gu
,
Jiying Wang
,
Yan-Yan Song
,
Xiaofeng Li
,
Junping Zhang
,
Wei Heng
,
Cuiying Zhang
,
Chunling Liu
,
Hui Li
,
Yingying Du
,
Jianfang Xu
,
Dan Wu
,
Xuwei Cai
,
Rui Meng
,
Xiaorong Dong
,
Yaoping Ruan
,
Liyan Jiang
Telehealth With Comprehensive Live-Fed Real-World Data as a Patient Care Platform for Lung Cancer: Implementation and Evaluation Study.
JMIR cancer
10 (2024)
Di Zheng
,
Yanhong Shang
,
Jian Ni
,
Ling Peng
,
Xiaoming Tan
,
ZhaoXia Dai
,
Yizhuo Zhao
,
Aiqin Gu
,
Jiying Wang
,
Yan-Yan Song
,
Xiaofeng Li
,
Junping Zhang
,
Wei Heng
,
Cuiying Zhang
,
Chunling Liu
,
Hui Li
,
Yingying Du
,
Jianfang Xu
,
Dan Wu
,
Xuwei Cai
,
Rui Meng
,
Xiaorong Dong
,
Yaoping Ruan
,
Liyan Jiang
Telehealth With Comprehensive Live-Fed Real-World Data as a Patient Care Platform for Lung Cancer: Implementation and Evaluation Study.
JMIR cancer
10 (2024)
Di Zheng
,
Yanhong Shang
,
Jian Ni
,
Ling Peng
,
Xiaoming Tan
,
ZhaoXia Dai
,
Yizhuo Zhao
,
Aiqin Gu
,
Jiying Wang
,
Yan-Yan Song
,
Xiaofeng Li
,
Junping Zhang
,
Wei Heng
,
Cuiying Zhang
,
Chunling Liu
,
Hui Li
,
Yingying Du
,
Jianfang Xu
,
Dan Wu
,
Xuwei Cai
,
Rui Meng
,
Xiaorong Dong
,
Yaoping Ruan
,
Liyan Jiang
Telehealth With Comprehensive Live-Fed Real-World Data as a Patient Care Platform for Lung Cancer: Implementation and Evaluation Study.
JMIR cancer
10 (2024)
Ling Gu
,
Xiaoying Wei
,
Zixiang Zhang
,
Wei Heng
Treatment Response to Immunotherapy After Crizotinib Resistance in a Patient With Pulmonary Sarcomatoid Carcinoma Harboring MET Exon 14 Skipping Mutation: A Case Report.
Clinical Medicine Insights. Oncology
16 (2022)